Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Rep. Lance Says Medical Device Tax Repeal ‘Critical to Creating Jobs’ for NJ

Washington, DC, June 11, 2013 — Following a tour and townhall-style meeting at C.R. Bard in Murray Hill last month, U.S. Representative Leonard Lance (NJ-07) said will continue to push for a repeal of the medical device tax and press the Food and Drug Administration to lessen regulatory burdens on the industry, calling it “critical to creating jobs for New Jersey and the Nation.”

“The burdensome tax on medical devices will increase costs, stifle investment and ultimately make health care more expensive for patients,” said Lance.  “Repealing the ObamaCare tax on medical devices will ensure that C.R. Bard and other Garden State companies continue to be world-wide leaders in the medical device industry.”

The medical device tax, passed as part of President Obama’s health care law, places a 2.3 percent excise tax on medical device manufacturers’ sales — not profits.

According to the Advanced Medical Technology Association (AdvaMed), New Jersey is home to more than 20,000 medical device jobs with an average annual salary of nearly $70,000. 

Those jobs have indirectly created another 43,000 positions in other sectors.  And the total economic impact of the device industry in New Jersey alone is nearly $13 billion each year.

“The tax will result in less spending on research and development, escalating costs on the newest technologies, reduced capital investments and ultimately loss of jobs right here at home in New Jersey,” said Lance.

Congressman Lance is a cosponsor of legislation to repeal the tax.  And last year he joined a strong bipartisan majority in the U.S. House of Representatives in voting to repeal the medical device tax. 

In March 2013, the U.S. Senate approved a bipartisan budget amendment calling for the end of a medical device tax.  “Repealing the 2.3 percent medical device tax is one of the things both Republicans and Democrats in Washington can agree on,” added Congressman Lance.